Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo

被引:68
|
作者
Glushakova, S
Grivel, JC
Suryanarayana, K
Meylan, P
Lifson, JD
Desrosiers, R
Margolis, L
机构
[1] NICHHD, Lab Mol & Cellular Biophys, NIH, Bethesda, MD 20892 USA
[2] SAIC Frederick, AIDS Vaccine Program, Lab Retroviral Pathogenesis, Frederick, MD 21702 USA
[3] CHU Vaudois, Inst Microbiol, CH-1011 Lausanne, Switzerland
[4] New England Reg Primate Res Ctr, Southborough, MA 01772 USA
关键词
D O I
10.1128/JVI.73.5.3968-3974.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The nef gene is important for the pathogenicity associated with simian immunodeficiency virus infection in rhesus monkeys and with human immunodeficiency virus type 1 (HIV-1) infection in humans. The mechanisms by which nef contributes to pathogenesis in vivo remain unclear,We investigated the contribution of nef to HIV-1 replication in human lymphoid tissue ex vivo by studying infection with parental HIV-I strain NL4-3 and with a nef mutant (Delta nefNL4-3). In human tonsillar histocultures, NL4-3 replicated to higher levels than Delta nefNL4-3 did. Increased, virus production with NL4-3 infection was associated with increased numbers of productively infected cells and greater loss of CD4(+) T cells over time, While the numbers of productively infected T cells were increased in the presence of nef, the levels of viral expression and production per infected T cell were similar whether the nef gene was present or not, Exogenous interleukin-2 (IL-2) increased HIV-1 production in NL4-3-infected tissue in a dose-dependent manner. In contrast, Delta nefNL4-3 production was enhanced only marginally by IL-2, Thus, Nef can facilitate HIV-1 replication in human lymphoid tissue ex vivo by increasing the numbers of productively infected cells and by increasing the responsiveness to IL-2 stimulation.
引用
收藏
页码:3968 / 3974
页数:7
相关论文
共 50 条
  • [1] CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo
    Schlaepfer, E
    Audigé, A
    von Beust, B
    Manolova, V
    Weber, M
    Joller, H
    Bachmann, MF
    Kundig, TM
    Speck, RF
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (22) : 12344 - 12354
  • [2] Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in Ex vivo-infected human lymphoid tissue
    Schindler, Michael
    Rajan, Devi
    Specht, Anke
    Ritter, Carolin
    Pulkkinen, Kati
    Saksela, Kalle
    Kirchhoff, Frank
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (23) : 13005 - 13014
  • [3] Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo
    Vanpouille, Christophe
    Bioncotto, Angelique
    Lisco, Andrea
    Brichacek, Beda
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (22) : 12458 - 12464
  • [4] Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
    Introini, Andrea
    Vanpouille, Christophe
    Fitzgerald, Wendy
    Broliden, Kristina
    Margolis, Leonid
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (140):
  • [5] Interleukin-2 for the treatment of human immunodeficiency virus infection
    Temesgen, Zelalem
    [J]. DRUGS OF TODAY, 2006, 42 (12) : 791 - 801
  • [6] The use of interleukin-2 in human immunodeficiency virus infection
    Anaya, JR
    Sias, JJ
    [J]. PHARMACOTHERAPY, 2005, 25 (01): : 86 - 95
  • [7] Determinants in HIV-1 Nef for enhancement of virus replication and depletion of CD4+ T lymphocytes in human lymphoid tissue ex vivo
    Homann, Stefanie
    Tibroni, Nadine
    Baumann, Ingo
    Sertel, Serkan
    Keppler, Oliver T.
    Fackler, Oliver T.
    [J]. RETROVIROLOGY, 2009, 6
  • [8] Determinants in HIV-1 Nef for enhancement of virus replication and depletion of CD4+ T lymphocytes in human lymphoid tissue ex vivo
    Stefanie Homann
    Nadine Tibroni
    Ingo Baumann
    Serkan Sertel
    Oliver T Keppler
    Oliver T Fackler
    [J]. Retrovirology, 6
  • [9] Use of interleukin-2 in immunotherapy of human immunodeficiency virus infection
    Reier, A
    Mitsuyasu, RT
    [J]. BIODRUGS, 1998, 10 (03) : 215 - 225
  • [10] Use of Interleukin-2 in Immunotherapy of Human Immunodeficiency Virus Infection
    Alice Reier
    Ronald T. Mitsuyasu
    [J]. BioDrugs, 1998, 10 : 215 - 225